nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR1D—meninx—meningioma	0.0766	0.0797	CbGeAlD
Loxapine—HTR3A—fourth ventricle—meningioma	0.0747	0.0776	CbGeAlD
Loxapine—HTR1B—dura mater—meningioma	0.0729	0.0757	CbGeAlD
Loxapine—HTR1D—dura mater—meningioma	0.0705	0.0733	CbGeAlD
Loxapine—HTR2C—choroid plexus—meningioma	0.0594	0.0617	CbGeAlD
Loxapine—HTR1B—trigeminal nerve—meningioma	0.0313	0.0326	CbGeAlD
Loxapine—DRD3—telencephalic ventricle—meningioma	0.0313	0.0325	CbGeAlD
Loxapine—HTR1D—trigeminal nerve—meningioma	0.0303	0.0315	CbGeAlD
Loxapine—HTR2A—choroid plexus—meningioma	0.0298	0.031	CbGeAlD
Loxapine—HTR3A—cranial nerve—meningioma	0.0266	0.0277	CbGeAlD
Loxapine—DRD1—telencephalic ventricle—meningioma	0.0224	0.0233	CbGeAlD
Loxapine—HTR1B—cranial nerve—meningioma	0.0223	0.0232	CbGeAlD
Loxapine—HTR1D—cranial nerve—meningioma	0.0216	0.0225	CbGeAlD
Loxapine—HTR1B—telencephalic ventricle—meningioma	0.0181	0.0189	CbGeAlD
Loxapine—SLC6A3—telencephalic ventricle—meningioma	0.018	0.0187	CbGeAlD
Loxapine—HTR1D—telencephalic ventricle—meningioma	0.0176	0.0183	CbGeAlD
Loxapine—HTR2C—telencephalic ventricle—meningioma	0.0174	0.0181	CbGeAlD
Loxapine—HTR7—cranial nerve—meningioma	0.0172	0.0179	CbGeAlD
Loxapine—HTR7—pons—meningioma	0.017	0.0177	CbGeAlD
Loxapine—HTR2A—trigeminal nerve—meningioma	0.0151	0.0157	CbGeAlD
Loxapine—HTR1A—telencephalic ventricle—meningioma	0.0146	0.0152	CbGeAlD
Loxapine—HTR7—telencephalic ventricle—meningioma	0.014	0.0146	CbGeAlD
Loxapine—DRD2—telencephalic ventricle—meningioma	0.0132	0.0138	CbGeAlD
Loxapine—HTR2A—cranial nerve—meningioma	0.0107	0.0112	CbGeAlD
Loxapine—HTR2A—pons—meningioma	0.0106	0.011	CbGeAlD
Loxapine—HTR1E—brainstem—meningioma	0.0104	0.0108	CbGeAlD
Loxapine—HTR5A—brain—meningioma	0.00974	0.0101	CbGeAlD
Loxapine—HTR2A—telencephalic ventricle—meningioma	0.00873	0.00907	CbGeAlD
Loxapine—HTR2A—pineal body—meningioma	0.00757	0.00787	CbGeAlD
Loxapine—DRD1—brainstem—meningioma	0.00606	0.0063	CbGeAlD
Loxapine—HTR3A—brainstem—meningioma	0.00585	0.00609	CbGeAlD
Loxapine—HTR1B—brainstem—meningioma	0.00491	0.00511	CbGeAlD
Loxapine—SLC6A3—brainstem—meningioma	0.00487	0.00506	CbGeAlD
Loxapine—DRD4—brain—meningioma	0.00482	0.00501	CbGeAlD
Loxapine—HTR1D—brainstem—meningioma	0.00475	0.00494	CbGeAlD
Loxapine—HTR2C—brainstem—meningioma	0.00471	0.00489	CbGeAlD
Loxapine—SLC6A4—brainstem—meningioma	0.00446	0.00464	CbGeAlD
Loxapine—HTR1E—brain—meningioma	0.00416	0.00432	CbGeAlD
Loxapine—HTR1A—brainstem—meningioma	0.00396	0.00412	CbGeAlD
Loxapine—SLC6A2—brainstem—meningioma	0.00393	0.00409	CbGeAlD
Loxapine—HTR7—brainstem—meningioma	0.00379	0.00394	CbGeAlD
Loxapine—ADRA1A—brainstem—meningioma	0.00365	0.0038	CbGeAlD
Loxapine—CHRM4—brain—meningioma	0.00365	0.00379	CbGeAlD
Loxapine—DRD2—brainstem—meningioma	0.00358	0.00372	CbGeAlD
Loxapine—DRD3—brain—meningioma	0.00339	0.00352	CbGeAlD
Loxapine—HTR2C—medulla oblongata—meningioma	0.00328	0.00341	CbGeAlD
Loxapine—HTR6—brain—meningioma	0.00326	0.00339	CbGeAlD
Loxapine—DRD5—brain—meningioma	0.00318	0.0033	CbGeAlD
Loxapine—HTR1B—spinal cord—meningioma	0.00305	0.00317	CbGeAlD
Loxapine—SLC6A3—spinal cord—meningioma	0.00303	0.00315	CbGeAlD
Loxapine—HRH2—brain—meningioma	0.00298	0.0031	CbGeAlD
Loxapine—HTR2C—spinal cord—meningioma	0.00293	0.00304	CbGeAlD
Loxapine—CHRM5—brain—meningioma	0.00285	0.00296	CbGeAlD
Loxapine—SLC6A4—spinal cord—meningioma	0.00278	0.00289	CbGeAlD
Loxapine—SLC6A2—medulla oblongata—meningioma	0.00274	0.00285	CbGeAlD
Loxapine—HTR7—medulla oblongata—meningioma	0.00264	0.00275	CbGeAlD
Loxapine—ADRA1B—brain—meningioma	0.0026	0.00271	CbGeAlD
Loxapine—HTR1A—spinal cord—meningioma	0.00246	0.00256	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—meningioma	0.00243	0.00252	CbGeAlD
Loxapine—DRD1—brain—meningioma	0.00243	0.00252	CbGeAlD
Loxapine—SLC6A3—cerebellum—meningioma	0.0024	0.0025	CbGeAlD
Loxapine—HTR2A—brainstem—meningioma	0.00236	0.00246	CbGeAlD
Loxapine—HTR7—spinal cord—meningioma	0.00235	0.00245	CbGeAlD
Loxapine—HTR3A—brain—meningioma	0.00234	0.00244	CbGeAlD
Loxapine—ADRA2C—spinal cord—meningioma	0.00216	0.00225	CbGeAlD
Loxapine—HTR1B—brain—meningioma	0.00197	0.00204	CbGeAlD
Loxapine—CHRM2—brain—meningioma	0.00196	0.00203	CbGeAlD
Loxapine—HTR1A—cerebellum—meningioma	0.00195	0.00203	CbGeAlD
Loxapine—SLC6A3—brain—meningioma	0.00195	0.00203	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—meningioma	0.00194	0.00201	CbGeAlD
Loxapine—HTR1D—brain—meningioma	0.0019	0.00198	CbGeAlD
Loxapine—HTR2C—brain—meningioma	0.00189	0.00196	CbGeAlD
Loxapine—HTR7—cerebellum—meningioma	0.00187	0.00194	CbGeAlD
Loxapine—ADRB1—brain—meningioma	0.00185	0.00192	CbGeAlD
Loxapine—ADRA1A—cerebellum—meningioma	0.0018	0.00187	CbGeAlD
Loxapine—SLC6A4—brain—meningioma	0.00179	0.00186	CbGeAlD
Loxapine—CHRM1—brain—meningioma	0.00178	0.00185	CbGeAlD
Loxapine—DRD2—cerebellum—meningioma	0.00177	0.00184	CbGeAlD
Loxapine—ADRA2A—spinal cord—meningioma	0.00173	0.0018	CbGeAlD
Loxapine—ADRA2C—cerebellum—meningioma	0.00172	0.00178	CbGeAlD
Loxapine—HTR2A—medulla oblongata—meningioma	0.00165	0.00171	CbGeAlD
Loxapine—CHRM3—brain—meningioma	0.00159	0.00166	CbGeAlD
Loxapine—HTR1A—brain—meningioma	0.00159	0.00165	CbGeAlD
Loxapine—SLC6A2—brain—meningioma	0.00157	0.00164	CbGeAlD
Loxapine—HTR7—brain—meningioma	0.00152	0.00158	CbGeAlD
Loxapine—HTR2A—spinal cord—meningioma	0.00147	0.00153	CbGeAlD
Loxapine—ADRA1A—brain—meningioma	0.00146	0.00152	CbGeAlD
Loxapine—DRD2—brain—meningioma	0.00143	0.00149	CbGeAlD
Loxapine—ADRA2C—brain—meningioma	0.00139	0.00145	CbGeAlD
Loxapine—ADRA2A—cerebellum—meningioma	0.00137	0.00142	CbGeAlD
Loxapine—HTR2A—cerebellum—meningioma	0.00116	0.00121	CbGeAlD
Loxapine—HRH1—brain—meningioma	0.00113	0.00118	CbGeAlD
Loxapine—ADRA2A—brain—meningioma	0.00111	0.00116	CbGeAlD
Loxapine—HTR2A—brain—meningioma	0.000946	0.000983	CbGeAlD
Loxapine—HTR2C—Signaling Pathways—SMO—meningioma	2.97e-05	0.000778	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PGR—meningioma	2.96e-05	0.000776	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—PDGFB—meningioma	2.94e-05	0.000772	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—PDGFB—meningioma	2.93e-05	0.000767	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SMO—meningioma	2.89e-05	0.000756	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PGR—meningioma	2.86e-05	0.000749	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PGR—meningioma	2.84e-05	0.000745	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SMO—meningioma	2.84e-05	0.000744	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PGR—meningioma	2.77e-05	0.000725	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TSHB—meningioma	2.76e-05	0.000722	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PGR—meningioma	2.72e-05	0.000714	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HES1—meningioma	2.64e-05	0.000692	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HES1—meningioma	2.64e-05	0.000691	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HES1—meningioma	2.62e-05	0.000687	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SMO—meningioma	2.62e-05	0.000686	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SMO—meningioma	2.58e-05	0.000675	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SMO—meningioma	2.57e-05	0.000674	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HES1—meningioma	2.57e-05	0.000672	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SMO—meningioma	2.56e-05	0.000672	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SMO—meningioma	2.55e-05	0.000669	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—ERBB2—meningioma	2.54e-05	0.000667	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SMO—meningioma	2.53e-05	0.000663	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HES1—meningioma	2.52e-05	0.000662	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SMO—meningioma	2.52e-05	0.000661	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PGR—meningioma	2.51e-05	0.000658	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HES1—meningioma	2.49e-05	0.000653	CbGpPWpGaD
Loxapine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—meningioma	2.48e-05	0.000649	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PGR—meningioma	2.47e-05	0.000647	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PGR—meningioma	2.46e-05	0.000646	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PGR—meningioma	2.46e-05	0.000644	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PGR—meningioma	2.45e-05	0.000642	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PGR—meningioma	2.42e-05	0.000636	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PGR—meningioma	2.42e-05	0.000634	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—TP53—meningioma	2.39e-05	0.000626	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HES1—meningioma	2.38e-05	0.000625	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SMO—meningioma	2.34e-05	0.000614	CbGpPWpGaD
Loxapine—HRH4—GPCR downstream signaling—AKT1—meningioma	2.33e-05	0.000611	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HES1—meningioma	2.27e-05	0.000596	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—PDGFB—meningioma	2.26e-05	0.000592	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—PDGFB—meningioma	2.26e-05	0.000591	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PGR—meningioma	2.25e-05	0.000589	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HES1—meningioma	2.24e-05	0.000588	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—PDGFB—meningioma	2.24e-05	0.000587	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—ERBB2—meningioma	2.22e-05	0.000581	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—PDGFB—meningioma	2.19e-05	0.000575	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—PTEN—meningioma	2.17e-05	0.000569	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—PDGFB—meningioma	2.16e-05	0.000566	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—PDGFB—meningioma	2.13e-05	0.000558	CbGpPWpGaD
Loxapine—HRH4—Signaling by GPCR—AKT1—meningioma	2.12e-05	0.000555	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HES1—meningioma	2.04e-05	0.000536	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—PDGFB—meningioma	2.04e-05	0.000535	CbGpPWpGaD
Loxapine—HTR1E—GPCR downstream signaling—AKT1—meningioma	2.03e-05	0.000532	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HES1—meningioma	2.02e-05	0.000531	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—AKT1—meningioma	2.02e-05	0.000529	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—TP53—meningioma	1.99e-05	0.000522	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—ERBB2—meningioma	1.97e-05	0.000517	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—ERBB2—meningioma	1.96e-05	0.000514	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HES1—meningioma	1.95e-05	0.000512	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HES1—meningioma	1.94e-05	0.00051	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PDGFB—meningioma	1.94e-05	0.000509	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PDGFB—meningioma	1.92e-05	0.000503	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HES1—meningioma	1.89e-05	0.000496	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—PTEN—meningioma	1.89e-05	0.000495	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HES1—meningioma	1.86e-05	0.000488	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—TP53—meningioma	1.86e-05	0.000488	CbGpPWpGaD
Loxapine—HTR1E—Signaling by GPCR—AKT1—meningioma	1.84e-05	0.000483	CbGpPWpGaD
Loxapine—HRH2—GPCR downstream signaling—AKT1—meningioma	1.81e-05	0.000474	CbGpPWpGaD
Loxapine—DRD5—GPCR downstream signaling—AKT1—meningioma	1.8e-05	0.000471	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PDGFB—meningioma	1.75e-05	0.000458	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PDGFB—meningioma	1.73e-05	0.000454	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HES1—meningioma	1.72e-05	0.00045	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HES1—meningioma	1.69e-05	0.000443	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HES1—meningioma	1.68e-05	0.000442	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—PTEN—meningioma	1.68e-05	0.000441	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—AKT1—meningioma	1.68e-05	0.000441	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HES1—meningioma	1.68e-05	0.00044	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HES1—meningioma	1.67e-05	0.000439	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—PTEN—meningioma	1.67e-05	0.000438	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PDGFB—meningioma	1.67e-05	0.000438	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PDGFB—meningioma	1.66e-05	0.000436	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HES1—meningioma	1.66e-05	0.000435	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HES1—meningioma	1.65e-05	0.000433	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—AKT1—meningioma	1.64e-05	0.00043	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—AKT1—meningioma	1.63e-05	0.000428	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PDGFB—meningioma	1.62e-05	0.000424	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PDGFB—meningioma	1.59e-05	0.000417	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—AKT1—meningioma	1.57e-05	0.000412	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HES1—meningioma	1.54e-05	0.000403	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—ERBB2—meningioma	1.51e-05	0.000397	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—ERBB2—meningioma	1.51e-05	0.000396	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TP53—meningioma	1.51e-05	0.000396	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—ERBB2—meningioma	1.5e-05	0.000394	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TP53—meningioma	1.48e-05	0.000388	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—ERBB2—meningioma	1.47e-05	0.000385	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PDGFB—meningioma	1.47e-05	0.000385	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—ERBB2—meningioma	1.45e-05	0.000379	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PDGFB—meningioma	1.44e-05	0.000378	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PDGFB—meningioma	1.44e-05	0.000378	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PDGFB—meningioma	1.44e-05	0.000376	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PDGFB—meningioma	1.43e-05	0.000375	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—ERBB2—meningioma	1.43e-05	0.000374	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PDGFB—meningioma	1.42e-05	0.000372	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PDGFB—meningioma	1.41e-05	0.000371	CbGpPWpGaD
Loxapine—HTR6—GPCR downstream signaling—AKT1—meningioma	1.39e-05	0.000363	CbGpPWpGaD
Loxapine—HTR7—GPCR downstream signaling—AKT1—meningioma	1.38e-05	0.000363	CbGpPWpGaD
Loxapine—HTR1D—GPCR downstream signaling—AKT1—meningioma	1.38e-05	0.000361	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—ERBB2—meningioma	1.37e-05	0.000358	CbGpPWpGaD
Loxapine—HTR1B—GPCR downstream signaling—AKT1—meningioma	1.35e-05	0.000353	CbGpPWpGaD
Loxapine—DRD4—GPCR downstream signaling—AKT1—meningioma	1.33e-05	0.000348	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PDGFB—meningioma	1.31e-05	0.000344	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—AKT1—meningioma	1.31e-05	0.000343	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—ERBB2—meningioma	1.3e-05	0.000341	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—PTEN—meningioma	1.29e-05	0.000338	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—meningioma	1.29e-05	0.000338	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—PTEN—meningioma	1.29e-05	0.000338	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—ERBB2—meningioma	1.29e-05	0.000337	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—PTEN—meningioma	1.28e-05	0.000336	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—AKT1—meningioma	1.28e-05	0.000335	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—AKT1—meningioma	1.26e-05	0.00033	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—AKT1—meningioma	1.26e-05	0.00033	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—PTEN—meningioma	1.25e-05	0.000329	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—AKT1—meningioma	1.25e-05	0.000328	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—AKT1—meningioma	1.25e-05	0.000328	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—AKT1—meningioma	1.25e-05	0.000328	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—PTEN—meningioma	1.23e-05	0.000323	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—AKT1—meningioma	1.22e-05	0.000321	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—PTEN—meningioma	1.22e-05	0.000319	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—AKT1—meningioma	1.2e-05	0.000316	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—AKT1—meningioma	1.19e-05	0.000313	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—AKT1—meningioma	1.19e-05	0.000311	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—AKT1—meningioma	1.18e-05	0.000309	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—ERBB2—meningioma	1.17e-05	0.000307	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—PTEN—meningioma	1.17e-05	0.000306	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—ERBB2—meningioma	1.16e-05	0.000304	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—meningioma	1.15e-05	0.000301	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—meningioma	1.14e-05	0.000299	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—AKT1—meningioma	1.14e-05	0.000298	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—ERBB2—meningioma	1.12e-05	0.000294	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—ERBB2—meningioma	1.11e-05	0.000292	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PTEN—meningioma	1.11e-05	0.000291	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTEN—meningioma	1.11e-05	0.00029	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PTEN—meningioma	1.1e-05	0.000287	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—AKT1—meningioma	1.09e-05	0.000285	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—ERBB2—meningioma	1.08e-05	0.000284	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—AKT1—meningioma	1.08e-05	0.000284	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—AKT1—meningioma	1.07e-05	0.000281	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—AKT1—meningioma	1.07e-05	0.00028	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—ERBB2—meningioma	1.07e-05	0.00028	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—AKT1—meningioma	1.06e-05	0.000279	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—meningioma	1.03e-05	0.000269	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—meningioma	1.02e-05	0.000268	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PTEN—meningioma	9.99e-06	0.000262	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—meningioma	9.93e-06	0.00026	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PTEN—meningioma	9.9e-06	0.000259	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—ERBB2—meningioma	9.84e-06	0.000258	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTEN—meningioma	9.79e-06	0.000257	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—meningioma	9.77e-06	0.000256	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—meningioma	9.74e-06	0.000255	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—meningioma	9.7e-06	0.000254	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—ERBB2—meningioma	9.68e-06	0.000254	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—ERBB2—meningioma	9.66e-06	0.000253	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—meningioma	9.65e-06	0.000253	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—meningioma	9.64e-06	0.000253	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—ERBB2—meningioma	9.63e-06	0.000252	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—ERBB2—meningioma	9.6e-06	0.000252	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PTEN—meningioma	9.55e-06	0.00025	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PTEN—meningioma	9.5e-06	0.000249	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—ERBB2—meningioma	9.5e-06	0.000249	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—ERBB2—meningioma	9.48e-06	0.000248	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—meningioma	9.32e-06	0.000244	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—meningioma	9.27e-06	0.000243	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PTEN—meningioma	9.24e-06	0.000242	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PTEN—meningioma	9.1e-06	0.000238	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—meningioma	9.02e-06	0.000236	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—meningioma	9.01e-06	0.000236	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTEN—meningioma	8.98e-06	0.000235	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—meningioma	8.88e-06	0.000233	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—meningioma	8.87e-06	0.000232	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—meningioma	8.85e-06	0.000232	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—meningioma	8.82e-06	0.000231	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—meningioma	8.81e-06	0.000231	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—ERBB2—meningioma	8.8e-06	0.000231	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—meningioma	8.8e-06	0.000231	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—meningioma	8.79e-06	0.00023	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—meningioma	8.74e-06	0.000229	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—meningioma	8.71e-06	0.000228	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—meningioma	8.68e-06	0.000228	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—meningioma	8.56e-06	0.000224	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—meningioma	8.42e-06	0.000221	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PTEN—meningioma	8.39e-06	0.00022	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—meningioma	8.31e-06	0.000218	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PTEN—meningioma	8.25e-06	0.000216	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PTEN—meningioma	8.24e-06	0.000216	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PTEN—meningioma	8.21e-06	0.000215	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—meningioma	8.18e-06	0.000214	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PTEN—meningioma	8.18e-06	0.000214	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PTEN—meningioma	8.1e-06	0.000212	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PTEN—meningioma	8.08e-06	0.000212	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—meningioma	8.07e-06	0.000211	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—meningioma	8.05e-06	0.000211	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—meningioma	8.03e-06	0.000211	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—meningioma	8.01e-06	0.00021	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—meningioma	7.98e-06	0.000209	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—meningioma	7.96e-06	0.000209	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—meningioma	7.91e-06	0.000207	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—meningioma	7.88e-06	0.000207	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—meningioma	7.58e-06	0.000199	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PTEN—meningioma	7.51e-06	0.000197	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—meningioma	7.48e-06	0.000196	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—meningioma	7.44e-06	0.000195	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—meningioma	7.43e-06	0.000195	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—meningioma	7.38e-06	0.000193	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—meningioma	7.33e-06	0.000192	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—meningioma	7.23e-06	0.000189	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—meningioma	7.11e-06	0.000186	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—meningioma	7.02e-06	0.000184	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—meningioma	6.82e-06	0.000179	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—meningioma	6.75e-06	0.000177	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—meningioma	6.72e-06	0.000176	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—meningioma	6.52e-06	0.000171	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—meningioma	6.49e-06	0.00017	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—meningioma	6.4e-06	0.000168	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—meningioma	6.37e-06	0.000167	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—meningioma	6.32e-06	0.000166	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—meningioma	6.31e-06	0.000165	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—meningioma	6.21e-06	0.000163	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—meningioma	5.76e-06	0.000151	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—meningioma	5.72e-06	0.00015	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—meningioma	5.7e-06	0.000149	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—meningioma	5.64e-06	0.000148	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—meningioma	5.63e-06	0.000148	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—meningioma	5.62e-06	0.000147	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—meningioma	5.6e-06	0.000147	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—meningioma	5.58e-06	0.000146	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—meningioma	5.53e-06	0.000145	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—meningioma	5.52e-06	0.000145	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—meningioma	5.51e-06	0.000144	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—meningioma	5.48e-06	0.000144	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—meningioma	5.33e-06	0.00014	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—meningioma	5.24e-06	0.000137	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—meningioma	5.17e-06	0.000136	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—meningioma	5.12e-06	0.000134	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—meningioma	4.83e-06	0.000127	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—meningioma	4.76e-06	0.000125	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—meningioma	4.75e-06	0.000124	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—meningioma	4.73e-06	0.000124	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—meningioma	4.72e-06	0.000124	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—meningioma	4.67e-06	0.000122	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—meningioma	4.66e-06	0.000122	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—meningioma	4.33e-06	0.000113	CbGpPWpGaD
